Skip to content

BTAI — Bioxcel Therapeutics Inc Institutional Holders · Q2 2026

Who owns Bioxcel Therapeutics Inc (BTAI)? 48 institutions reported holding $8.69M in SEC 13F filings for Q2 2026 (period ended 2026-06-30). Largest holders: Millennium Management LLC ($3.0M), Oaktree Capital Management LP ($1.9M), Vanguard Group Inc ($1.5M).

RankInstitutionValueSharesChange
1MILLENNIUM MANAGEMENT LLC$3.0M2.1MAdded
2OAKTREE CAPITAL MANAGEMENT LP$1.9M1.4MAdded
3VANGUARD GROUP INC$1.5M1.1MAdded
4Oaktree Fund Advisors, LLC$346,274245,585Added
5GEODE CAPITAL MANAGEMENT, LLC$341,911242,251Added
6BlackRock, Inc.$253,001179,433Added
7UBS Group AG$222,871158,065Added
8CITADEL ADVISORS LLC$210,400149,220New
9STATE STREET CORP$129,88692,118Hold
10FMR LLC$127,32390,300Hold
11&PARTNERS$117,85983,588Added
12JONES FINANCIAL COMPANIES LLLP$82,71263,139Trimmed
13NORTHERN TRUST CORP$79,40856,318Added
14HighTower Advisors, LLC$57,81041,000Hold
15Quadrature Capital Ltd$53,63438,038New
16Headlands Technologies LLC$36,03425,556New
17StoneX Group Inc.$29,16420,684New
18Beacon Pointe Advisors, LLC$26,56118,837Trimmed
19SUSQUEHANNA INTERNATIONAL GROUP, LLP$24,25217,200New
20Portfolio Strategies, Inc.$23,73216,831Added
21Virtu Financial LLC$23,00015,967New
22OSAIC HOLDINGS, INC.$22,86016,214Hold
23TWO SIGMA SECURITIES, LLC$15,22210,796New
24Diversify Advisory Services, LLC$13,00515,000New
25DIVERSIFY WEALTH MANAGEMENT, LLC$13,00515,000Hold

Source: SEC Form 13F filings · as of 2026-06-30